心血管疾病包括冠心病（心絞痛、心肌梗死）、心力衰竭、高血壓性心臟病、心律失常等，目前位于導(dǎo)致人類死亡病因的首位。黃芩苷可通過減輕心肌炎性損傷、減輕心肌氧化損傷、抑制心肌細(xì)胞凋亡、抑制血小板過度激活、抑制心肌纖維化、調(diào)節(jié)免疫平衡、改善線粒體功能、促進心肌細(xì)胞增殖、促進血管新生以減輕心肌損傷和改善心功能，治療心血管疾病?？偨Y(jié)了黃芩苷治療心血管疾病的藥理作用研究進展，為黃芩苷的臨床用藥提供參考。

Cardiovascular diseases, including coronary heart disease (angina pectoris, myocardial infarction), heart failure, hypertensive heart disease, arrhythmia, etc., are currently the leading causes of human mortality. Baicalin can alleviate myocardial inflammatory injury, reduce myocardial oxidative damage, inhibit myocardial cell apoptosis, inhibit platelet overactivation, inhibit myocardial fibrosis, regulate immune balance, improve mitochondrial function, promote myocardial cell proliferation, promote angiogenesis, and reduce myocardial injury through multiple targets and pathways, thereby improving cardiac function. This article summarizes the pharmacological research progress of baicalin in treatment of cardiovascular diseases, providing reference for the clinical use of baicalin.

R285

攀枝花市指導(dǎo)性科技計劃（2024ZD-S-122）